| NCT06915025 | Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer | RECRUITING | PHASE3 | 2025-07-09 | 2032-10-31 | 2032-10-31 |
| NCT06283459 | Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 | COMPLETED | PHASE1, PHASE2 | 2024-06-04 | 2025-03-07 | 2025-03-07 |
| NCT05739981 | Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer | RECRUITING | PHASE1, PHASE2 | 2023-02-10 | 2028-01-30 | 2026-08-30 |
| NCT03393884 | Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2018-09-05 | 2025-11-30 | 2024-07-25 |
| NCT02850419 | Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients | WITHDRAWN | PHASE2 | 2017-03 | 2020-02 | 2019-12 |
| NCT02480374 | Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer | COMPLETED | PHASE1 | 2015-09 | 2017-05 | 2017-05 |
| NCT02112656 | Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) | COMPLETED | PHASE3 | 2014-06 | 2020-04-27 | 2020-04-27 |
| NCT00826085 | Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall | COMPLETED | PHASE1, PHASE2 | 2013-02 | 2016-06 | 2015-12 |
| NCT01640847 | MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases | WITHDRAWN | PHASE2 | 2012-07 | 2013-07 | 2013-06 |
| NCT01464593 | Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) | TERMINATED | PHASE2 | 2011-09 | 2013-06 | 2013-05 |
| NCT00617981 | Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) | COMPLETED | PHASE3 | 2008-05 | 2016-08 | 2013-01 |
| NCT00441376 | A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver | COMPLETED | PHASE1 | 2007-02 | 2009-12 | 2008-10 |